The CRIS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CRIS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The CRIS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View CRIS Detailed Price Forecast - CNN Money||View CRIS Detailed Summary - Google Finance|
|View CRIS Detailed Summary - Yahoo! Finance||View CRIS Stock Research & Analysis - Zacks.com|
|View CRIS Trends & Analysis - Trade-Ideas||View CRIS Major Holders - Barrons|
|View CRIS Call Transcripts - NASDAQ||View CRIS Breaking News & Analysis - Seeking Alpha|
|View CRIS Annual Report - CompanySpotlight.com||View CRIS OTC Short Report - OTCShortReport.com|
|View CRIS Fundamentals - TradeKing||View CRIS SEC Filings - Bar Chart|
|View Historical Prices for CRIS - The WSJ||View Performance/Total Return for CRIS - Morningstar|
|View the Analyst Estimates for CRIS - MarketWatch||View the Earnings History for CRIS - CNBC|
|View the CRIS Earnings - StockMarketWatch||View CRIS Buy or Sell Recommendations - MacroAxis|
|View the CRIS Bullish Patterns - American Bulls||View CRIS Short Pain Metrics - ShortPainBot.com|
|View CRIS Stock Mentions - StockTwits||View CRIS Stock Mentions - PennyStockTweets|
|View CRIS Stock Mentions - Twitter||View CRIS Investment Forum News - Investor Hub|
|View CRIS Stock Mentions - Yahoo! Message Board||View CRIS Stock Mentions - Seeking Alpha|
|View Insider Transactions for CRIS - SECform4.com||View Insider Transactions for CRIS - Insider Cow|
|View CRIS Major Holdings Summary - CNBC||View Insider Disclosure for CRIS - OTC Markets|
|View Insider Transactions for CRIS - Yahoo! Finance||View Institutional Holdings for CRIS - NASDAQ|
|View CRIS Stock Insight & Charts - FinViz.com||View CRIS Investment Charts - StockCharts.com|
|View CRIS Stock Overview & Charts - BarChart||View CRIS User Generated Charts - Trading View|
Curis Announces Leadership Change
Posted on Monday September 24, 2018
LEXINGTON, Mass., Sept. 24, 2018 /PRNewswire/ -- Curis, Inc. (CRIS), a biotechnology company focused on the development and commercialization of innovative therapeutics for the treatment of cancer, today announced a change in leadership with the appointment of James E. Dentzer as President and Chief Executive Officer effective immediately. In addition, Mr. Dentzer will become a member of the Curis Board of Directors. Mr. Dentzer, who joined Curis in 2016, was promoted earlier this year to Chief Operating Officer to manage all functions outside of research and development, including business development, manufacturing, quality, human resources, finance, legal, IT, and investor and public relations.
Report: Developing Opportunities within Q2, Ormat Technologies, The Andersons, Comstock Resources, Freshpet, and Curis — Future Expectations, Projections Moving into 2018
Posted on Wednesday August 29, 2018
NEW YORK, Aug. 29, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Q2 ...
Curis to Present at the Baird 2018 Global Healthcare Conference
Posted on Tuesday August 28, 2018
LEXINGTON, Mass., Aug. 28, 2018 /PRNewswire/ -- Curis, Inc. (CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of cancer, today announced that the Company will present at the Baird 2018 Global Healthcare Conference on Wednesday, September 5 at 2:35-3:05 PM in Session III - Empire Ballroom B, Mezzanine Level of the InterContinental New York Barclay in New York. The presentation will be held using a fireside-chat format in which Ali Fattaey, Ph.D. President and Chief Executive Officer, will provide a brief overview of the Company's pipeline of drug candidates and business strategy, after which an equity analyst will moderate a question and answer session. A live webcast of the presentation will be available by visiting the investors section of Curis' website http://investors.curis.com/events-and-presentations.
Edited Transcript of CRIS earnings conference call or presentation 2-Aug-18 12:30pm GMT
Posted on Sunday August 05, 2018
Q2 2018 Curis Inc Earnings Call